Ivabradine - the first selective sinus node If channel inhibitor in the treatment of stable angina
Authors:
Open Access
- 1 February 2006
- journal article
- review article
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 60 (2) , 222-228
Abstract
Heart rate, a major determinant of angina in coronary disease, is also an important predictor of cardiovascular mortality. Lowering heart rate is therefore one of the most important therapeutic approaches in the treatment of stable angina pectoris. To date, beta-blockers and some calcium-channel antagonists reduce heart rate, but their use may be limited by adverse reactions or contraindications. Heart rate is determined by spontaneous electrical pacemaker activity in the sinoatrial node controlled by the I(f) current. Ivabradine is the first specific heart rate-lowering agent that has completed clinical development for stable angina pectoris. It is selective for the I(f) current, lowering heart rate at concentrations that do not affect other cardiac ionic currents. Specific heart-rate lowering with ivabradine reduces myocardial oxygen demand, simultaneously improving oxygen supply. Ivabradine has no negative inotropic or lusitropic effects, preserving ventricular contractility, and does not change any major electrophysiological parameters unrelated to heart rate. Randomised clinical studies in patients with stable angina show that ivabradine effectively reduces heart rate, improves exercise capacity and reduces the number of angina attacks. It has superior anti-anginal and anti-ischaemic activity to placebo and is non-inferior to atenolol and amlodipine. Ivabradine therefore offers a valuable approach to lowering heart rate exclusively and provides an attractive alternative to conventional treatment for a wide range of patients with confirmed stable angina.Keywords
This publication has 47 references indexed in Scilit:
- Heart Rate Lowering by Specific and Selective If Current Inhibition with IvabradineDrugs, 2004
- Characteristics of a contemporary population with angina pectorisThe American Journal of Cardiology, 1994
- Adverse Reactions with ??-Adrenoceptor Blocking Drugs An UpdateDrug Safety, 1993
- Influence of heart rate on mortality among persons with hypertension: The Framingham StudyAmerican Heart Journal, 1993
- Minimum heart rate and coronary atherosclerosis: Independent relations to global severity and rate of progression of angiographic lesions in men with myocardial infarction at a young ageAmerican Heart Journal, 1992
- Influence of heart rate on mortality after acute myocardial infarctionThe American Journal of Cardiology, 1990
- Effects of antihypertensives on plasma lipids and lipoprotein metabolismAmerican Heart Journal, 1988
- The epidemiology of resting heart rate in a national sample of men and women: Associations with hypertension, coronary heart disease, blood pressure, and other cardiovascular risk factorsAmerican Heart Journal, 1988
- Transient myocardial ischemia after abrupt withdrawal of antianginal therapy in chronic stable anginaThe American Journal of Cardiology, 1988
- Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trialsThe American Journal of Cardiology, 1986